Evidence map›Paper›PMID 30022164›Full record

ArticleNature2018

Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development.

Corey N Miller, Irina Proekt, Jakob von Moltke, Kristen L Wells, Aparna R Rajpurkar, Haiguang Wang, Kristin Rattay, Imran S Khan, Todd C Metzger, Joshua L Pollack and 10 more

Abstract read
In one paragraph

Article in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 216 papers.

0numbers the graph read from it
0cells of the map it votes in
216citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

216 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Runx3 instructs AireJournal of autoimmunity · 2026
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

156 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Corey N MillerDiabetes Center, University of California, San Francisco, San Francisco, CA, USA.
Irina ProektDiabetes Center, University of California, San Francisco, San Francisco, CA, USA.
Jakob von MoltkeDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Kristen L WellsDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Aparna R RajpurkarDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Haiguang WangCenter for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Kristin RattayDivision of Developmental Immunology, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Imran S KhanDiabetes Center, University of California, San Francisco, San Francisco, CA, USA.
Todd C MetzgerDiabetes Center, University of California, San Francisco, San Francisco, CA, USA.
Joshua L PollackDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Adam C FriesBiological Imaging Development Center and Department of Pathology, University of California, San Francisco, CA, USA.
Wint W LwinDiabetes Center, University of California, San Francisco, San Francisco, CA, USA.
Eric J WigtonDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.
Audrey V ParentDiabetes Center, University of California, San Francisco, San Francisco, CA, USA.
Bruno KyewskiDivision of Developmental Immunology, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
David J ErleDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Kristin A HogquistCenter for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Lars M SteinmetzDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Richard M LocksleyDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Mark S AndersonDiabetes Center, University of California, San Francisco, San Francisco, CA, USA. mark.anderson@ucsf.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
Role of miRNAs in Th2-Driven inflammation in AsthmaP01HL107202 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANSEL, KARL MARK · 2012 to 2023
$23.3M
Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRUMMEL, MATTHEW F · 2003 to 2019
$21.8M
GENETICS TRAINING PROGRAM FOR PHD CANDIDATEST32GM007790 · NIGMS · STANFORD UNIVERSITY · PI BRUNET, ANNE, KINGSLEY, DAVID M · 1985 to 2020
$12.8M
MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
Thymic medullary epithelial cell turnover and control of immune toleranceR37AI097457 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mark S Anderson · 2017 to 2026
$4.0M
Parasite immunity orchestrated by type 2 immune cellsR01AI026918 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOCKSLEY, RICHARD M · 1988 to 2022
$3.8M
TCR signal strength in thymic selectionR37AI039560 · NIAID · UNIVERSITY OF MINNESOTA · PI HOGQUIST, KRISTIN A. · 2012 to 2021
$3.7M
Using human stem cell-derived thymic epithelium to remodel T1D immune toleranceU01DK107383 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S, BLUESTONE, JEFFREY A · 2016 to 2019
$2.3M
Thymic medullary epithelial cell turnover and control of immune toleranceR01AI097457 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 2012 to 2016
$1.9M
BD FACSAria Fusion Cell SorterS10OD021822 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEE, MICHAEL R. · 2016 to 2016
$573k
NHLBI NIH HHS P01 HL107202NIAID NIH HHS R01 AI026918NIAID NIH HHS R01 AI097457NIAID NIH HHS R37 AI039560NIAID NIH HHS R37 AI097457NIAID NIH HHS T32 AI007334NIDDK NIH HHS P30 DK063720NIDDK NIH HHS U01 DK107383NIGMS NIH HHS T32 GM007618NIGMS NIH HHS T32 GM007790NIH HHS S10 OD021822
6 · The paper itself

Abstract

The thymus is responsible for generating a diverse yet self-tolerant pool of T cells

Indexed as

AIRE ProteinAnimalsCellular MicroenvironmentDoublecortin-Like KinasesEpithelial CellsFemaleHumansImmune ToleranceInterleukin-4InterleukinsIntracellular Signaling Peptides and ProteinsMaleMiceMice, Inbred BALB CMice, Inbred C57BLProtein Serine-Threonine KinasesAIRE ProteinDCLK1 protein, humanDclk1 protein, mouseDoublecortin-Like KinasesInterleukin-4InterleukinsIntracellular Signaling Peptides and ProteinsMydgf protein, mouseProtein Serine-Threonine KinasesTranscription FactorsTRPM5 protein, humanTRPM Cation Channels

Identifiers

PMID30022164
PMCPMC6062473

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.